Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: Treatment with immunosuppressive therapy

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

Frank C. Arnett, Steven M. Edworthy, D. Blöch et al. · Arthritis & Rheumatism · 1988 · 19.8K citations

PRINCIPLES OF INTERNAL MEDICINE

Theresa Harrison, Rayhaan Adams, Paul B. Beeson et al. · The American Journal of the Medical Sciences · 1955 · 1.3K citations

Medicine, Medical Ethics, General Internal Medicine +1

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

P W Askenase, Betty J. Hayden, Richard K. Gershon · The Journal of Experimental Medicine · 1975 · 430 citations · Full text

Cyclophosphamide Pretreatment, Cyclophosphamide Treatment, Allergy Medicine +17

Mortality Rate in Rheumatoid Arthritis Patients Developing Necrotizing Scleritis or Peripheral Ulcerative Keratitis

C. Stephen Foster, S. Lance Forstot, Louis A. Wilson · Ophthalmology · 1984 · 345 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +10

Suppression of human B lymphocyte function by cyclophosphamide.

Thomas R. Cupps, Lynn C. Edgar, A S Fauci · The Journal of Immunology · 1982 · 182 citations · Full text